2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| CK Life Sciences Intl (Holdings) Inc | — | 2,842,638 | Nov 25, 2025 |
| Sealbond Ltd | — | 2,842,638 | Nov 25, 2025 |
| Conjoint Inc. | — | 2,842,638 | Nov 25, 2025 |
| Duncan Gregory Scott | CEO | 138,835 | Feb 28, 2024 |
| Gendreau Roger Michael | — | 88,085 | Feb 28, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 6, 2026 | Grosswald Ralph | SVP OF OPERATIONS | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 5, 2026 | Mar 6, 2026 | Walsh Angela | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 5, 2026 | Mar 6, 2026 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 5, 2026 | Mar 6, 2026 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 4, 2025 | Dec 5, 2025 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 4, 2025 | Dec 5, 2025 | Walsh Angela | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 4, 2025 | Dec 5, 2025 | Grosswald Ralph | SVP OF OPERATIONS | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 4, 2025 | Dec 5, 2025 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2025 | Nov 25, 2025 | Sealbond Ltd | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2025 | Jul 1, 2025 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2025 | Jul 1, 2025 | Whitley Richard James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2025 | Jul 1, 2025 | Grosswald Ralph | SVP OF OPERATIONS | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2025 | Jul 1, 2025 | Thomas John C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2025 | Jul 1, 2025 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2025 | Jul 1, 2025 | Keefer David R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2025 | Jul 1, 2025 | Walsh Angela | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2025 | Jul 1, 2025 | De La Rosa Abel | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 23, 2025 | Whitley Richard James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 23, 2025 | Keefer David R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 23, 2025 | Thomas John C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 18, 2025 | Jun 23, 2025 | De La Rosa Abel | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 20, 2025 | Conjoint Inc. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 12, 2025 | Mar 17, 2025 | CK Life Sciences Intl (Holdings) Inc | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 17, 2024 | Yu Ying Choi Alan Abel | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 17, 2024 | Toh Kean Meng Melvin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 17, 2024 | Sealbond Ltd | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 26, 2024 | Feb 28, 2024 | Pridgen William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | Thomas John C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | Whitley Richard James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | Keefer David R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | Burch Richard Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | De La Rosa Abel | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | Walsh Angela | SVP OF FINANCE | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | Grosswald Ralph | SVP OF OPERATIONS | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 26, 2024 | Feb 28, 2024 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 21, 2023 | Aug 22, 2023 | Pridgen William | Director | Buy | 78.8 | +15,335 | 2.06% | ✗ | $20K |
| Aug 17, 2023 | Aug 18, 2023 | Duncan Gregory Scott | CEO | Buy | 91.3 | +25,000 | 77.02% | ✗ | $31.2K |
| Jun 15, 2023 | Jun 20, 2023 | Keefer David R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | De La Rosa Abel | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | Thomas John C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | Burch Richard Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | Whitley Richard James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | Pridgen William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2022 | Feb 15, 2023 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2022 | Dec 14, 2022 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2022 | Dec 14, 2022 | Walsh Angela | SVP OF FINANCE | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2022 | Dec 14, 2022 | Grosswald Ralph | SVP OF OPERATIONS | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2022 | Dec 14, 2022 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 8, 2022 | Dec 12, 2022 | Whitley Richard James | Director | Sell | 27.5 | -1,800 | -72.00% | ✗ | $466.4 |
| Jun 23, 2022 | Jun 30, 2022 | Whitley Richard James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jun 30, 2022 | Pridgen William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jun 30, 2022 | Burch Richard Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jun 30, 2022 | Keefer David R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jun 30, 2022 | Thomas John C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jun 30, 2022 | De La Rosa Abel | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jun 30, 2022 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jun 30, 2022 | Grosswald Ralph | SVP OF OPERATIONS | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jun 30, 2022 | Walsh Angela | SVP OF FINANCE | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jun 30, 2022 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 23, 2022 | May 24, 2022 | Walsh Angela | SVP OF FINANCE | Buy | 90.0 | +2,000 | 200.00% | ✗ | $9.2K |
| May 23, 2022 | May 24, 2022 | Duncan Gregory Scott | CEO | Buy | 91.3 | +7,500 | 30.05% | ✗ | $33.9K |
| May 18, 2022 | May 19, 2022 | Whitley Richard James | Director | Buy | 90.0 | +500 | 25.00% | ✗ | $2.3K |
| May 18, 2022 | May 19, 2022 | Pridgen William | Director | Buy | 47.5 | +241 | 0.03% | ✗ | $1.1K |
| May 17, 2022 | May 18, 2022 | Pridgen William | Director | Buy | 82.5 | +13,450 | 1.84% | ✗ | $58.9K |
| Mar 29, 2022 | Mar 30, 2022 | Pridgen William | Director | Buy | 55.0 | +600 | 0.08% | ✗ | $3K |
| Mar 23, 2022 | Mar 24, 2022 | Pridgen William | Director | Buy | 61.3 | +2,197 | 0.30% | ✗ | $12K |
| Feb 14, 2022 | Burch Richard Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 27, 2022 | Jan 28, 2022 | Pridgen William | Director | Buy | 68.8 | +4,180 | 0.58% | ✗ | $25K |
| Jan 7, 2022 | Jan 7, 2022 | De La Rosa Abel | Director | Buy | 91.3 | +4,000 | 100.00% | ✗ | $23.6K |
| Jan 6, 2022 | Jan 7, 2022 | Whitley Richard James | Director | Buy | 91.3 | +1,800 | 900.00% | ✗ | $10.3K |
| Jan 4, 2022 | Jan 5, 2022 | Keefer David R | Director | Buy | 91.3 | +5,000 | 64.04% | ✗ | $29K |
| Jan 3, 2022 | Jan 4, 2022 | Pridgen William | Director | Buy | 61.3 | +2,215 | 0.31% | ✗ | $12K |
| Jan 4, 2022 | Jan 4, 2022 | Thomas John C | Director | Buy | 90.0 | +1,000 | 100.00% | ✗ | $5.7K |
| Dec 23, 2021 | Dec 23, 2021 | Whitley Richard James | Director | Buy | 90.0 | +200 | 100.00% | ✗ | $1.1K |
| Dec 21, 2021 | Dec 22, 2021 | Pridgen William | Director | Buy | 78.8 | +8,827 | 1.24% | ✗ | $50K |
| Dec 21, 2021 | Dec 22, 2021 | Duncan Gregory Scott | CEO | Buy | 91.3 | +5,000 | 25.05% | ✗ | $27.6K |
| Jul 7, 2021 | Jul 9, 2021 | Pridgen William | Director | Buy | 55.0 | +942 | 0.13% | ✓ | $6K |
| Jun 22, 2021 | Jun 23, 2021 | Pridgen William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2021 | Jun 23, 2021 | Burch Richard Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2021 | Jun 23, 2021 | Whitley Richard James | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2021 | Jun 23, 2021 | Thomas John C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2021 | Jun 23, 2021 | Keefer David R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 22, 2021 | Jun 23, 2021 | De La Rosa Abel | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 21, 2021 | Jun 22, 2021 | Walsh Angela | SVP OF FINANCE | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 21, 2021 | Jun 22, 2021 | Grosswald Ralph | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 21, 2021 | Jun 22, 2021 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 6, 2021 | Apr 7, 2021 | Duncan Gregory Scott | CEO | Buy | 77.5 | +382 | 1.95% | ✓ | $2.4K |
| Apr 5, 2021 | Apr 6, 2021 | Duncan Gregory Scott | CEO | Buy | 95.0 | +15,675 | 401.51% | ✓ | $96.8K |
| Apr 5, 2021 | Apr 6, 2021 | Duncan Gregory Scott | CEO | Buy | 95.0 | +15,675 | 401.51% | ✓ | $96.8K |
| Jan 28, 2021 | Feb 1, 2021 | Walsh Angela | VP of Finance | Buy | 90.0 | +1,000 | 100.00% | ✗ | $7.3K |
| Jan 28, 2021 | Feb 1, 2021 | Pridgen William | Director | Buy | 91.3 | +3,500 | 100.00% | ✗ | $26.1K |
| Jan 28, 2021 | Feb 1, 2021 | Keefer David R | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 11, 2021 | Jan 12, 2021 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 11, 2021 | Jan 12, 2021 | Grosswald Ralph | VP of Finance | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 11, 2021 | Jan 12, 2021 | Walsh Angela | VP of Finance | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2021 | Jan 12, 2021 | Gendreau Roger Michael | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 6, 2021 | Jan 8, 2021 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 21, 2020 | Dec 21, 2020 | Duncan Gregory Scott | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 21, 2020 | Dec 21, 2020 | Grosswald Ralph | President | Neutral | 52.5 | - | 0.00% | ✗ | - |